IL1A and neoplasm: In CRC, TAMs showed pro-inflammatory properties and expressed cytokines such as IFNγ, IL6 and IL1, which activated type-1 polarised CD4+- T cells (Th1) cells mediating an anti-tumour immune response [23,25].